Clinical Trial

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

Name: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo — clinical trial record (NCT06804811)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in children (6 to \< 12 years old) with nonsegmental vitiligo.

Protocol Amendment History 1 change

notable Trial sites reduced: 86 -> 79 locations 2026-07-23

Trial Details

NCT Number	NCT06804811
Lead Sponsor	Incyte Corporation
Conditions	NonSegmental Vitiligo
Enrollment	250 participants
Start Date	2025-11-13
Primary Completion	2027-04-30 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-22